Report
Oliver Metzger

Amplifon : Q2 review – slower performance, as expected

>Slower top line growth due to headwinds - Amplifon’s reported Q2 revenue of € 541.4m (+7.6% y-o-y), -1%/0% vs ODDO BHF/consensus. Sales growth in local currency was 5.0% (vs 7.5% est.). Organic growth was just 0.5% vs our forecast of 2.6%. Europe posted an organic decline of 0.4% and 50bp external growth. The Americas region was up by 7.5% organically and acquisitions made a contribution of 260bp. APAC declined by 3.4% organically, but primarily Bay Audio contributed...
Underlying
Amplifon S.p.A.

Amplifon is multinational company engaged in the ddistribution, fitting, adaptation and personalization of hearing systems (hearing aids) designed to meet the needs of those suffering from hearing disabilities. Co. is also engaged in the sale of accessories such as batteries, consumables and spare parts, as well as in the distribution of biomedical devices. Co. is active in 20 different countries: Italy, France, Germany, Switzerland, The Netherlands, Belgium, Luxembourg, the U.K., Ireland, Spain, Portugal, Hungary, Turkey, the U.S., Canada, Australia, New Zealand, India, Egypt, and in Poland.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Oliver Metzger

ResearchPool Subscriptions

Get the most out of your insights

Get in touch